News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

January

25

electroCore, Inc. Announces Three Abstracts to be Presented at International Stroke Conference 2022

Clinical Research Conducted on Non-invasive Vagus Nerve Stimulation (nVNS) for the Acute Treatment of...

20

TriSalus Life Sciences Announces Collaboration with the University of Colorado Anschutz Medical Campus

Three-year program aims to advance research on innovative immuno-oncology treatments for patients with liver...

18

electroCore Announces Shareholder Letter and Full-Year 2021 Business Update

Company anticipates full-year 2021 revenue of approximately $5.5 million, an approximately 55% increase over...

17

VisionWeb and Neurolens Collaborate to Increase Prism Specificity

Through VisionWeb’s ordering platform, prism can now be entered to the 1/100th prism diopter...

12

gammaCore™ Non-Invasive Vagus Nerve Stimulation(nVNS) Receives Breakthrough Device Designation for Treatment of Posttraumatic Stress Disorder (PTSD)

nVNS reduces symptoms of PTSD by 31% in sham-controlled study ROCKAWAY, N.J., Jan. 12, 2022 (GLOBE...

11

electroCore, Inc. Broadens Patient Access to gammaCore with Launch of U.S. Telehealth Portal and Online Store

E-Commerce platform allows patients to obtain prescriptions, purchase nVNS devices, and receive training ROCKAWAY,...

10

ATEC Announces Preliminary 2021 Revenue Results and 2022 Guidance

Full-year 2021 U.S. organic revenue growth of 50% to 51% driven primarily by accelerated...

9

Exagen and Queen Mary University of London Announce Exclusive License and Collaboration Agreement

Collaboration to develop novel patented molecular signatures for rheumatoid arthritis biologic therapeutic selection SAN...

6

Global Liver Institute and TriSalus Life Sciences Launch New Liver Cancer Resource Hub

“Liver Central” is a comprehensive online guide for liver cancer researchers, clinicians and patients...

16

electroCore, Inc. Provides Update on Global Distribution Partners

ROCKAWAY, NJ, Dec. 16, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine...

15

electroCore, Inc. Announces The Launch of a New Online Shop in the United Kingdom

ROCKAWAY, NJ, Dec. 15, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine...

15

Neurolens Announces 2022 O.D. Advisory Board

Coppell, Texas, December 15, 2021 – In order to ensure continued focus on addressing the...